Cost-effectiveness of adherence therapy versus health education for people with schizophrenia

"Non-adherence to anti-psychotics is common, expensive and affects recovery. We therefore examine the cost-effectiveness of adherence therapy for people with schizophrenia by multi-centre randomised trial in Amsterdam, London, Leipzig and Verona."

Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries
A Patel, et al.
Cost Effectiveness and Resource Allocation, 2013, 11:12

Read more here.